Overview
Karin Potthoff practices in Freiburg, Germany. Ms. Potthoff is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Febrile Neutropenia, Breast Cancer, Agranulocytosis, and Acute Myelomonocytic Leukemia.
Her clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Cholangiocarcinoma (Bile Duct Cancer).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisMs. Potthoff isAdvanced. Learn about Agranulocytosis.
- Breast CancerMs. Potthoff isAdvanced. Learn about Breast Cancer.
- Febrile NeutropeniaMs. Potthoff isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Myelomonocytic LeukemiaMs. Potthoff isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Cholangiocarcinoma (Bile Duct Cancer)Ms. Potthoff isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic Myelomonocytic Leukemia (CMML)Ms. Potthoff isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Colorectal CancerMs. Potthoff isExperienced. Learn about Colorectal Cancer.
- Multiple MyelomaMs. Potthoff isExperienced. Learn about Multiple Myeloma.
- Pancreatic CancerMs. Potthoff isExperienced. Learn about Pancreatic Cancer.